Table 4 Procedural and hospital outcomes. Data are expressed as percentage (frequency) or median (IQR)
Ticagrelor (n = 142) | Clopidogrel (n = 259) | P | |
|---|---|---|---|
Procedural outcomes (unadjusted analysis) | |||
TIMI flow post-PCI | 3 (3–3) | 3 (3–3) | 0.002 |
Procedural success (TIMI 3 and stenosis <50%) | 99.0 (115/116) | 89.9 (151/168) | 0.001 |
Procedural success (TIMI 2–3 and stenosis <50%) | 100.0 (116/116) | 95.8 (161/168) | 0.044 |
STR% | 89 (50–100) | 100 (50–100) | 0.482 |
STR ≥ 50% | 78.1 (82/105) | 78.2 (122/156) | 0.879 |
STR% ≥ 70% | 60.0 (63/105) | 66.7 (104/156) | 0.294 |
Hospital outcomes (unadjusted analysis) | |||
In-hospital all-cause death | 0.7 (1) | 5.4 (14) | 0.024 |
In-hospital CV death | 0.7 (1) | 5.4 (14) | 0.024 |
In-hospital non-fatal AMI | 3.5 (5) | 1.2 (3) | 0.14 |
Ischaemic CVA | 0.4 (1) | 0.7 (1) | 1.00 |
Total CVA (ischaemic or haemorrhagic) | 0.4 (1) | 0.7 (1) | 1.00 |
Hospital MACE | 4.9 (7) | 6.9 (18) | 0.52 |
Definite stent thrombosis | 1.4 (2) | 0.8 (2) | 0.62 |
Final LVEF [%] | 50 (40–55) | 48 (40–55) | 0.55 |
CPK peak [UI/L] | 1347 (535–2590) | 1376 (677–2491) | 0.77 |
Hospital stay [days] | 4 (4–6) | 5 (4–6) | 0.84 |